Serum Chemokine CXCL7 as a Diagnostic Biomarker for Colorectal Cancer

Serum Chemokine CXCL7 as a Diagnostic Biomarker for Colorectal Cancer

Identification of effective biomarkers is crucial for monitoring the treatment and remission of colorectal cancer (CRC) and improving survival. It is particularly important to diagnose CRC before the tumor metastasizes (stage I–II disease) where possible, to provide the greatest opportunity for pati...

Full description

Bibliographic Details
Main Authors: Longhai Li, Lihua Zhang, Yu Tian, Ting Zhang, Guangliang Duan, Yankui Liu, Yuan Yin, Dong Hua, Xiaowei Qi, Yong Mao
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-10-01
Series:Frontiers in Oncology
Subjects:
cancer biomarker
colorectal cancer
CXCL7
diagnosis
serum
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2019.00921/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2019.00921/full

Similar Items